BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 28552767)

  • 1. Parenteral nanoemulsions of risperidone for enhanced brain delivery in acute psychosis: Physicochemical and in vivo performances.
    Đorđević SM; Santrač A; Cekić ND; Marković BD; Divović B; Ilić TM; Savić MM; Savić SD
    Int J Pharm; 2017 Nov; 533(2):421-430. PubMed ID: 28552767
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Parenteral nanoemulsions as promising carriers for brain delivery of risperidone: Design, characterization and in vivo pharmacokinetic evaluation.
    Đorđević SM; Cekić ND; Savić MM; Isailović TM; Ranđelović DV; Marković BD; Savić SR; Timić Stamenić T; Daniels R; Savić SD
    Int J Pharm; 2015 Sep; 493(1-2):40-54. PubMed ID: 26209070
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Experimental design in formulation of diazepam nanoemulsions: physicochemical and pharmacokinetic performances.
    Đorđević SM; Radulović TS; Cekić ND; Ranđelović DV; Savić MM; Krajišnik DR; Milić JR; Savić SD
    J Pharm Sci; 2013 Nov; 102(11):4159-72. PubMed ID: 24114833
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intranasal nanoemulsion based brain targeting drug delivery system of risperidone.
    Kumar M; Misra A; Babbar AK; Mishra AK; Mishra P; Pathak K
    Int J Pharm; 2008 Jun; 358(1-2):285-91. PubMed ID: 18455333
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combined use of biocompatible nanoemulsions and solid microneedles to improve transport of a model NSAID across the skin: In vitro and in vivo studies.
    Ilić T; Savić S; Batinić B; Marković B; Schmidberger M; Lunter D; Savić M; Savić S
    Eur J Pharm Sci; 2018 Dec; 125():110-119. PubMed ID: 30287408
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biocompatible Nanoemulsions for Improved Aceclofenac Skin Delivery: Formulation Approach Using Combined Mixture-Process Experimental Design.
    Isailović T; Ðorđević S; Marković B; Ranđelović D; Cekić N; Lukić M; Pantelić I; Daniels R; Savić S
    J Pharm Sci; 2016 Jan; 105(1):308-23. PubMed ID: 26539935
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Formulation and Evaluation of Neuroactive Drug Loaded Chitosan Nanoparticle for Nose to Brain Delivery: In-vitro Characterization and In-vivo Behavior Study.
    Qureshi M; Aqil M; Imam SS; Ahad A; Sultana Y
    Curr Drug Deliv; 2019; 16(2):123-135. PubMed ID: 30317997
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mucoadhesive nanoemulsion-based intranasal drug delivery system of olanzapine for brain targeting.
    Kumar M; Misra A; Mishra AK; Mishra P; Pathak K
    J Drug Target; 2008 Dec; 16(10):806-14. PubMed ID: 18988064
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preparation and in vivo evaluation of a gel-based nasal delivery system for risperidone.
    Gu F; Ma W; Meng G; Wu C; Wang Y
    Acta Pharm; 2016 Dec; 66(4):555-562. PubMed ID: 27749254
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Formulation and characterization of nanoemulsion-based drug delivery system of risperidone.
    Kumar M; Pathak K; Misra A
    Drug Dev Ind Pharm; 2009 Apr; 35(4):387-95. PubMed ID: 19016058
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Microstructure and biopharmaceutical performances of curcumin-loaded low-energy nanoemulsions containing eucalyptol and pinene: Terpenes' role overcome penetration enhancement effect?
    Nikolic I; Mitsou E; Pantelic I; Randjelovic D; Markovic B; Papadimitriou V; Xenakis A; Lunter DJ; Zugic A; Savic S
    Eur J Pharm Sci; 2020 Jan; 142():105135. PubMed ID: 31682974
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development of nanoemulsion for efficient brain parenteral delivery of cefuroxime: designs, characterizations, and pharmacokinetics.
    Harun SN; Nordin SA; Gani SSA; Shamsuddin AF; Basri M; Basri HB
    Int J Nanomedicine; 2018; 13():2571-2584. PubMed ID: 29731632
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Microsphere delivery of Risperidone as an alternative to combination therapy.
    D'Souza S; Faraj J; DeLuca P
    Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt A):631-9. PubMed ID: 23892159
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A PET study evaluating dopamine D2 receptor occupancy for long-acting injectable risperidone.
    Remington G; Mamo D; Labelle A; Reiss J; Shammi C; Mannaert E; Mann S; Kapur S
    Am J Psychiatry; 2006 Mar; 163(3):396-401. PubMed ID: 16513859
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nanoemulsions containing a synthetic chalcone as an alternative for treating cutaneous leshmaniasis: optimization using a full factorial design.
    de Mattos CB; Argenta DF; Melchiades Gde L; Cordeiro MN; Tonini ML; Moraes MH; Weber TB; Roman SS; Nunes RJ; Teixeira HF; Steindel M; Koester LS
    Int J Nanomedicine; 2015; 10():5529-42. PubMed ID: 26366075
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Curcumin Loaded PEGylated Nanoemulsions Designed for Maintained Antioxidant Effects and Improved Bioavailability: A Pilot Study on Rats.
    Đoković JB; Savić SM; Mitrović JR; Nikolic I; Marković BD; Randjelović DV; Antic-Stankovic J; Božić D; Cekić ND; Stevanović V; Batinić B; Aranđelović J; Savić MM; Savić SD
    Int J Mol Sci; 2021 Jul; 22(15):. PubMed ID: 34360758
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sustained release of risperidone from biodegradable microspheres prepared by in-situ suspension-evaporation process.
    An T; Choi J; Kim A; Lee JH; Nam Y; Park J; Sun Bk; Suh H; Kim CJ; Hwang SJ
    Int J Pharm; 2016 Apr; 503(1-2):8-15. PubMed ID: 26899975
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Design and in vivo evaluation of solid lipid nanoparticulate systems of Olanzapine for acute phase schizophrenia treatment: Investigations on antipsychotic potential and adverse effects.
    Joseph E; Reddi S; Rinwa V; Balwani G; Saha R
    Eur J Pharm Sci; 2017 Jun; 104():315-325. PubMed ID: 28408348
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intranasal haloperidol-loaded miniemulsions for brain targeting: Evaluation of locomotor suppression and in-vivo biodistribution.
    El-Setouhy DA; Ibrahim AB; Amin MM; Khowessah OM; Elzanfaly ES
    Eur J Pharm Sci; 2016 Sep; 92():244-54. PubMed ID: 27154259
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development of oral solid self-emulsifying lipid formulations of risperidone with improved in vitro dissolution and digestion.
    Kazi M; Al-Qarni H; Alanazi FK
    Eur J Pharm Biopharm; 2017 May; 114():239-249. PubMed ID: 28159721
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.